Curaleaf Holdings (CURLF) Interest Expenses (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Interest Expenses of $299.0 million for Q4 2025, up 110855.93% year-over-year from N/an in Q4 2024, and up 110855.93% quarter-over-quarter from -$270000.0 in Q4 2024.
Curaleaf Holdings (CURLF) Interest Expenses (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Interest Expenses history runs 7 years deep, the most recent figure standing at $299.0 million for Q4 2025.
- In Q4 2025, Interest Expenses rose 110855.93% year-over-year to $299.0 million; the TTM figure through Dec 2025 stood at $299.0 million (up 6215.54% YoY), while the FY2025 annual figure was $586.0 million, up 39.79% from the prior year.
- Interest Expenses for Q4 2025 stood at $299.0 million, up from -$270000.0 in the prior quarter.
- The five-year high for Interest Expenses was $299.0 million in Q4 2025, with the low at -$270000.0 in Q4 2024.
- The 5-year median for Interest Expenses is $4.4 million (2022), against an average of $38.3 million.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses sank 101.19% in 2024, then surged 110855.93% in 2025.
- Curaleaf Holdings' Interest Expenses stood at $32.2 million in 2021, then sank by 41.59% to $18.8 million in 2022, then increased by 20.38% to $22.6 million in 2023, then tumbled by 101.19% to -$270000.0 in 2024, then soared by 110855.93% to $299.0 million in 2025.
- Business Quant data shows CURLF's Interest Expenses at $299.0 million in Q4 2025, -$270000.0 in Q4 2024, and $5.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 268.49 Mn |
| Jun 30, 2026 | 268.49 Mn |
| Dec 31, 2025 | 299.04 Mn |
| Dec 31, 2025 | 299.04 Mn |
| Dec 31, 2024 | -270,000.00 |
| Dec 31, 2024 | -270,000.00 |
| Sep 30, 2024 | 5.01 Mn |
| Sep 30, 2024 | 5.01 Mn |
| Dec 31, 2023 | 22.62 Mn |
| Dec 31, 2023 | 22.62 Mn |
| Sep 30, 2023 | 892,000.00 |
| Sep 30, 2023 | 892,000.00 |
| Dec 31, 2022 | 18.79 Mn |
| Dec 31, 2022 | 18.79 Mn |
| Sep 30, 2022 | 3.74 Mn |
| Sep 30, 2022 | 3.74 Mn |
| Sep 30, 2021 | 32.17 Mn |
| Sep 30, 2021 | 32.17 Mn |
| Jun 30, 2021 | 937,000.00 |
| Jun 30, 2021 | 937,000.00 |